Krystal Biotech
KRYS
KRYS
135 hedge funds and large institutions have $1.37B invested in Krystal Biotech in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more capital invested
Capital invested by funds: $1.35B → $1.37B (+$15.4M)
4% less funds holding
Funds holding: 140 → 135 (-5)
15% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 26
Holders
135
Holding in Top 10
5
Calls
$5.51M
Puts
$3.1M
Top Buyers
| 1 | +$35.3M | |
| 2 | +$24.4M | |
| 3 | +$10.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.53M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.44M |
Top Sellers
| 1 | -$53.9M | |
| 2 | -$13.3M | |
| 3 | -$9.04M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$7.59M |
| 5 |
Millennium Management
New York
|
-$4.3M |